Profiling the immune response to COVID-19 vaccination in vulnerable populations (COVULPOP).
Latest Information Update: 11 Nov 2021
At a glance
- Drugs AZD 1222 (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
- Acronyms COVULPOP
- 11 Nov 2021 New trial record